• 5437 Citations
  • 33 h-Index
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2002

Thalidomide in multiple myeloma

Richardson, P., Hideshima, T. & Anderson, K., Jan 1 2002, In : Biomedicine and Pharmacotherapy. 56, 3, p. 115-128 14 p.

Research output: Contribution to journalArticle

22 Scopus citations
2001

Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase

Vonderheide, R. H., Anderson, K. S., Hahn, W. C., Butler, M. O., Schultze, J. L. & Nadler, L. M., Jan 1 2001, In : Clinical Cancer Research. 7, 11, p. 3343-3348 6 p.

Research output: Contribution to journalArticle

95 Scopus citations

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals

Vonderheide, R. H., Schultze, J. L., Anderson, K. S., Maecker, B., Butler, M. O., Xia, Z., Von Bergwelt-Baildon, M. S., Bedor, M. M., Hoar, K. M., Schnipper, D. R., Stephans, K. F., Hahn, W. C., Nadler, L. M., Wucherpfennig, K. W., Kuroda, M. J., Letvin, N. L. & Brooks, M. W., Dec 1 2001, In : Cancer Research. 61, 23, p. 8366-8370 5 p.

Research output: Contribution to journalArticle

75 Scopus citations

Linking genomics to immunotherapy by reverse immunology mmmunomics' in the New Millennium

Maecker, B., Von Bergwelt-Baildon, M. S., Anderson, K. S., Vonderheide, R. H. & Schultze, J. L., 2001, In : Current Molecular Medicine. 1, 5, p. 609-619 11 p.

Research output: Contribution to journalArticle

27 Scopus citations

Tumour immunotherapy: New tools, new treatment modalities and new T-cell antigens

Schultze, J. L., Maecker, B., Von Bergwelt-Baildon, M. S., Anderson, K. S. & Vonderheide, R. H., Feb 1 2001, In : Vox Sanguinis. 80, 2, p. 81-89 9 p.

Research output: Contribution to journalReview article

21 Scopus citations
2000

Potential of antigen-specific adoptive immunotherapy using peptide/mhc tetramers and microbeads for highyield purification of cytotoxic t lymphocytes from peripheral blood

Andersen, K. S., Wucherpfennig, K. A., Nicholas Haining, W., Schultze, J. L., Maecker, B., Xia, Z., Butler, M. O., Vonderheide, R. H. & Nadler, L. M., Dec 1 2000, In : Blood. 96, 11 PART I, p. 177a

Research output: Contribution to journalArticle

1994

A role for calnexin (IP90) in the assembly of class II MHC molecules

Anderson, K. S. & Cresswell, P., Feb 1 1994, In : EMBO Journal. 13, 3, p. 675-682 8 p.

Research output: Contribution to journalArticle

105 Scopus citations
1993
Open Access
221 Scopus citations

Intracellular transport of class I MHC molecules in antigen processing mutant cell lines

Anderson, K. S., Alexander, J., Wei, M. & Cresswell, P., Jan 1 1993, In : Journal of Immunology. 151, 7, p. 3407-3419 13 p.

Research output: Contribution to journalArticle

101 Scopus citations
1992

Transport and expression of class I MHC glycoproteins in an antigen- processing mutant cell line

Click, E. M., Anderson, K. S., Androlewicz, M. J., Wei, M. L. & Cresswell, P., 1992, In : Cold Spring Harbor symposia on quantitative biology. 57, p. 571-578 8 p.

Research output: Contribution to journalArticle

7 Scopus citations
1991

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis

Anderson, K., Cresswell, P., Gammon, M., Hermes, J., Williamson, A. & Zweerink, H., Aug 1 1991, In : Journal of Experimental Medicine. 174, 2, p. 489-492 4 p.

Research output: Contribution to journalArticle

Open Access
197 Scopus citations
1988

Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole

Pearson, W. R., Reinhart, J., Sisk, S. C., Anderson, K. S. & Adler, P. N., Jan 1 1988, In : Journal of Biological Chemistry. 263, 26, p. 13324-13332 9 p.

Research output: Contribution to journalArticle

74 Scopus citations